Brand check
Is Solvin Cold banned in India?
Last checked 19 September 2026. A few details are still being checked against the original document.
Solvin Cold is not banned in India as of 19 Sep 2026; as a chlorpheniramine + phenylephrine FDC it is restricted from use in children below four years by S.O. 1717(E) of 15 Apr 2025 and S.O. 4595(E).
- Classification
- Restricted under Section 26A, Drugs and Cosmetics Act, 1940
- Decided by
- CDSCO / Ministry of Health and Family Welfare
- Reference
- S.O. 1717(E), 15 Apr 2025; S.O. 4595(E), 18 Aug 2026
- Latest action
- 19 September 2026
- Last checked
- 19 September 2026details being verified
Photo: syrup-bottle-pills by rawpixel (cc0). All photo credits.
CDSCO: List of prohibited FDC drugs, 156 FDCs dated 02.08.2024
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.
Key facts
- Governing authority
- CDSCO, Ministry of Health and Family Welfare
- Restriction
- S.O. 1717(E), 15 Apr 2025; S.O. 4595(E), 18 Aug 2026
- Composition
- Paracetamol + chlorpheniramine + phenylephrine (being verified)
- Manufacturer
- Ipca Laboratories
- Not on
- The Aug 2024 156-FDC list
Solvin Cold is Ipca's cold and flu range, combining paracetamol with chlorpheniramine maleate and phenylephrine in tablet and syrup forms. It is not banned in India. Like every product that pairs chlorpheniramine with phenylephrine, it is now subject to a licence condition about young children.
S.O. 1717(E) of 15 April 2025 required chlorpheniramine + phenylephrine drops and syrups to carry the statement that the product "shall not be used in children below four years" and not to be promoted for that age. S.O. 4595(E) of 18 August 2026 applied the same condition to all fixed-dose combinations containing the two drugs, which brings the paracetamol-containing tablets into scope. Neither order withdraws the product; both change what the label must say and who it may be marketed to.
Solvin Cold was not in the August 2024 list of 156 prohibited FDCs. That list included the cetirizine + paracetamol + phenylephrine formula used by Cheston Cold and several levocetirizine cold tablets, but not the chlorpheniramine version.
A proposal from the DGHS to add a red "not below four years" warning to all cough syrups was before the Drugs Consultative Committee on 19 September 2026. If adopted, packs will change again, but the medicine's legal status will not.
Adults and children over four can use the product as labelled. For younger children a doctor should choose the treatment.
What this means for you
Unchanged for adults and older children
Solvin Cold tablets and syrup remain licensed for the ages on the label.
Not for children under four
Ask a doctor about alternatives for toddlers with a cold.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Batches flagged in CDSCO alerts
No NSQ batch on record. No product matching this name appears in CDSCO or state-lab NSQ alerts from Jan 2019 to July 2026. Absence from the alerts is not proof of quality, check your batch number.
Official sources and primary records
- Medical Dialogues: Health ministry restricts chlorpheniramine + phenylephrine FDCs for children below 4, mandates warning labelsNewsMedical Dialogues
- Business Standard: Cough syrups may soon get a red warning against use for children under 4NewsBusiness Standard · 19 September 2026
- CDSCO: List of prohibited FDC drugs, 156 FDCs dated 02.08.2024RegulatorCDSCO · 2 August 2024